References
- Jevons MP. “Celbenin”-resistant staphylococci. BMJ. 1961;1:1–10.
- Cosgrove SE, Qi Y, Kaye KS, et al. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, the length of stay, and hospital charges. Infect Control Hosp Epidemiol. 2005;26(2):166–174.
- Tacconelli E, De Angelis G, Cataldo MA, et al. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother. 2008;61(1):26–38.
- Kaier K, Hagist C, Frank U, et al. Two time-series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection. Infect Control Hosp Epidemiol. 2009;30(4):346–353.
- Pearson A, Chronias A, Murray M. Voluntary and mandatory surveillance for methicillin-resistant staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) bacteraemia in England. J Antimicrob Chemother. 2009;64(Suppl.1):i11–i17.
- Garattini L, Cornago D, De Compadri P. Pricing and reimbursement of in-patent drugs in seven European countries: a comparative analysis. Health Policy. 2007;82(3):330–339.
- Byrne FM, Wilcox MH. MRSA prevention strategies and current guidelines. Injury. 2011;42(S5):S3–S6.
- Ayliffe GAJ, Duckworth GJ, Brumfitt W, et al. Guideline for the control of epidemic methicillin-resistant Staphylococcus aureus. J Hosp Infect. 1986;7:193–201.
- Magiorakos AP, Leens E, Drouvot V, et al. Pathways to clean hands: highlights of successful hand hygiene implementation strategies in Europe. Euro Surveill. 2010;15(18):pii=19560.
- Vandenbroucke-Grauls CM. Methicillin-resistant Staphylococcus aureus control in hospitals: the Dutch experience. Infect Control Hosp Epidemiol. 1996;17(8):512–513.
- Otter JA, Herdman MT, Williams B, et al. Low prevalence of meticilin-resistant Staphylococcus aureus carriage at hospital admission: implications for risk-factor-based vs universal screening. J Hosp Infect. 2013;83(2):114–121.
- EMA. Sales of veterinary antimicrobial agents in 19 EU/EEA countries in 2013. Fifth ESVAC report. London: EMA; 2015. [ cited 2016 Aug 10]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Report/2015/10/WC500195687.pdf
- The RAISIN Working Group. “RAISIN”–a national programme for early warning, investigation and surveillance of healthcare-associated infection in France. Euro Surveill. 2009;14(46):pii=19408.
- Jans B, Catry B, Mertens K, et al. Fifty percent reduction of MRSA incidence in Belgian acute care hospitals: yes we can! Brussels: Belgian NSIH Hospital Network; 2011. [ cited 2016 Aug 10]. Available from: http://www.nsih.be/download/MRSA/MRSA_20102/Poster_ECMMID_jans_P1090.pdf
- Schweickert B, Noll I, Feig M, et al. MRSA-surveillance in Germany: data from the Antibiotic Resistance Surveillance System (ARS) and the mandatory surveillance of MRSA in blood. Eur J Clin Microbiol Infect Dis. 2012;31(8):1855–1865.
- Carlet J, Astagneau P, Brun-Buisson C, et al. French national program for prevention of healthcare-associated infections and antimicrobial resistance, 1992–2008: positive trends, but perseverance needed. Infect Control Hosp Epidemiol. 2009;30(8):737–745.
- Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut. Empfehlung zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus aureus-Stämmen (MRSA) in Krankenhäusern und anderen medizinischen Einrichtungen: mitteilung der Kommission Krankenhaushygiene und Infektionsprävention am RKI. [Recommendation on the prevention and control of methicillin-resistant Staphylococcus aureus strains (MRSA) in hospitals and other medical establishments: commission communication on hospital hygiene and infection prevention at the RKI]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 1999;42:954–958. German.
- Struelens MJ, Ronveaux O, Jans B, et al. Methicillin-resistant Staphylococcus aureus epidemiology and control in Belgian hospitals, 1991 to 1995. Infect Control Hosp Epidemiol. 1996;17(8):503–508.
- Rodriguez-Baño J, Bischofberger C, Álvarez-Lerma F, et al. Surveillance and control of methicillin-resistant Staphylococcus aureus in Spanish hospitals. A GEIH-SEIMC and SEMPSPH consensus document. Enferm Infecc Microbiol Clin. 2008;26(5):285–298.
- Pan A, Bombana E, Tura G, et al. A survey of methicillin-resistant Staphylococcus aureus control strategies in Italy. Infection. 2013;41(4):783–789.
- Huttner B, Goossens H, Verheij T, et al. Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infec Dis. 2010;10(1):17–31.
- Department of Health Expert Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection. Implementation of modified admission MRSA screening guidance for NHS. London: Department of Health; 2014. [ cited 2016 Nov 20]. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/345144/Implementation_of_modified_admission_MRSA_screening_guidance_for_NHS.pdf
- Ridge A. UK antibiotic usage and resistance: fact file. Veterinary policy research foundation; 2016 [cited 2016 Dec 8]. Available from: https://vprf.files.wordpress.com/2016/12/amr-fact-file-12.pdf
- BMEL. Guidelines for the prudent use of veterinary antimicrobial drugs–with notes for guidance. Bonn: Bundesministerium für Ernährung und Landwirtschaft; 2010. [ cited 2016 Aug 10]. Available from: http://www.bmel.de/SharedDocs/Downloads/EN/Agriculture/AnimalProtection/Antibiotikaleitlinien
- AMCRA. Plan for veterinary antibiotic policy until 2020. Brussels: Centre of Expertise on Antimicrobial Consumption and Resistance in Animals; 2014. [ cited 2016 Aug 5]. Available from: http://www.amcra.be/sites/default/files/bestanden/AMCRA%202020%20finaal_EN_0.pdf
- Health Council of the Netherlands. Antibiotics in food animal production and resistant bacteria in humans. The Hague: Health Council of the Netherlands; 2011. [ cited 2016 Aug 3]. Available from: https://www.gezondheidsraad.nl/sites/default/files/201116E_Antibiotica_in_food_animal.pdf
- Ecoantibio. national action plan for the reduction of the risks of antibiotic resistance in veterinary medicine. Paris: Ministry of Agriculture; 2012. [ cited 2016 Aug 10]. Available from: http://agriculture.gouv.fr/sites/minagri/files/documents/pdf/130208PlanABR-GB-2012-BD_cle8786a1.pdf
- Landman T. Issues and methods in comparative politics: an introduction. 3rd ed. London: Routledge; 2008.
- Cacace M, Ettelt S, Mays N, et al. Assessing quality in cross-country comparisons of health systems and policies: towards a set of generic quality criteria. Health Policy. 2013;112(1–2):156–162.
- Stegmueller D. How many countries for multilevel modeling? A comparison of frequentist and Bayesian approaches. Am J Pol Sci. 2013;57(3):748–761.
- Cabana MD, Rand CS, Powe NR, et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282(15):1458–1465.
- Ammerlaan HS, Kluytmans JA, Berkhout H, et al. Eradication of carriage with methicillin-resistant Staphylococcus aureus: effectiveness of a national guideline. J Antimicrob Chemother. 2011;66(10):2409–2417.
- Van Rijen MML, Kluytmans JAJW. Costs and benefits of the MRSA Search and Destroy policy in a Dutch hospital. Eur J Clin Microbiol Infect Dis. 2009;28(10):1245–1252.
- Kilpatrick C, Prieto J, Wigglesworth N. Single room isolation to prevent the transmission of infection: development of a patient journey tool to support safe practice. Br J Infect Control. 2008;9(6):19–25.
- Macdonald L. Transmission based precautions literature review: patient placement (isolation/cohorting). Glasgow: Health Protection Scotland; 2014. [ cited 2016 Dec 8]. Available from: http://www.nipcm.scot.nhs.uk/documents/tbp-patient-placement-isolation-and-cohorting/
- Simon A, Exner M, Kramer A, et al. Implementing the MRSA recommendations made by the Commission for Hospital Hygiene and Infection Prevention (KRINKO) of 1999 – current considerations by the DGKH Management Board. GMS Krankenhhyg Interdiszip. 2009;4(1):Doc02.
- Formoso G, Paltrinieri B, Marata AM, et al. Feasibility and effectiveness of a low cost campaign on antibiotic prescribing in Italy: community level, controlled, non-randomised trial. BMJ. 2013;347:f5391.
- Chaintarli K, Ingle SM, Bhattacharya A,A, et al. Impact of a UK-wide campaign to tackle antimicrobial resistance on self-reported knowledge and behaviour change. BMC Public Health. 2016;16(1):393.
- Rodriguez C, González E, Garcia A, et al. Implementation of the e-bug project in Spain. J Antimicrob Chemother. 2011;66(Suppl.5):v85–v87.
- Llor C, Cots J. The sales of antibiotics without prescription in pharmacies in Catalonia, Spain. Clin Infect Dis. 2009;48:1345–1349.
- Robotham JV, Deeny SR, Fuller C, et al. Cost-effectiveness of national mandatory screening of all admissions to English National Health Service hospitals for meticillin-resistant Staphylococcus aureus: a mathematical modelling study. Lancet Infec Dis. 2016;16:348–356.
- Silbergeld EK, Graham J, Price LB. Industrial food animal production, antimicrobial resistance, and human health. Annu Rev Public Health. 2008;29:151–169.
- Cuny C, Wieler LH, Witte W,W. Livestock-associated MRSA: the impact on humans. Antibiotics (Basel). 2015;4(4):521–543.
- Adriaenssens N, Coenen S, Versporten A, et al. European surveillance of antimicrobial consumption (ESAC): outpatient antibiotic use in Europe (1997–2009). J Antimicrob Chemother. 2011;66:vi3–vi12.